CD8A and breast cancer: It also blocks ECM-receptor interactions and upregulates critical genes including Cxcl3, Met, Col8a1, Oasl2, and Mmp12. As a result, this leads to an increase in the proportion of CD4+ and CD8+ T cells in tissue and tumor sites in mice bearing 4T1 mammary tumors [531].